News

Filter

Current filters:

None

7875 to 7884 of 95927 results

Victoza sales boost Novo Nordisk

03-02-2012

Danish insulin giant Novo Nordisk (NVO: N) yesterday reported full-year 2011 sales of 66.35 billion Danish…

DiabetesFinancialNovo NordiskPharmaceuticalVictoza

2011 financial briefs for Alkermes, Allergan, Gilead and Vertex

03-02-2012

Among the plethora of financial results being reported by US biotech and pharmaceutical companies were…

AlkermesAllerganBiotechnologyFinancialGilead SciencesPharmaceuticalVertex

Strong international drug sales drive Ipsen 2011

03-02-2012

French drugmaker Ipsen (Euronext: IPN) reported that, in full-year 2011, group drug sales grew by 5.7%…

FinancialIpsenPharmaceutical

Biotech deal-making off to a strong start in 2012, says Burrill

02-02-2012

Swiss drug major Roche's hostile $5.7 billion bid for the tools and sequencing systems company Illumina…

BiotechnologyFinancialLicensingMergers & AcquisitionsNorth America

Sucampo’s OBD drug meets Ph III endpoint

02-02-2012

USA-based Sucampo Pharmaceuticals (Nasdaq: SCMP) and Japanese drug major Takeda Pharmaceuticals’…

Gastro-intestinalsLubiprostonePharmaceuticalResearchSucampoTakeda Pharmaceuticals

European thrombosis market in urgent need for enhanced products, says F&S

02-02-2012

The increasing incidence of thrombosis, paralleled by the maturing life cycles of existing products,…

Cardio-vascularEuropeMarkets & MarketingPharmaceuticalResearch

NICE issues negative guidance for Zytiga

02-02-2012

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has issued new draft…

EuropeJanssenJohnson & JohnsonOncologyPharmaceuticalPricingRegulationZytiga

AstraZeneca profits rise, but more jobs to go

02-02-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning unveiled a set of financial results for…

AstraZenecaFinancialPharmaceutical

7875 to 7884 of 95927 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top